Foreign Corrupt Practices Act (FCPA) For Bio/Pharmaceuticals and Medical Devices

Adhere to Regulatory Guidelines to Ensure Compliant Relationships with Foreign Officials and Build Global Anti-Bribery and Corruption Procedures

July 15 - 16, 2008
Arlington, VA, The Ritz-Carlton, Pentagon City

The Foreign Corrupt Practices Act (FCPA) makes it a felony for a U.S. citizen to offer or make a corrupt payment to a foreign official or political party to obtain or retain business. In many countries, hospitals are operated by the government, which makes doctors foreign officials. This causes the FCPA to be a key area of concern for bio/pharmaceutical and medical device companies operating overseas. This event provides attendees with tools to help build and maintain compliant relationships with foreign officials to ensure all international activities follow the guidelines of the Foreign Corrupt Practices Act (FCPA).

For more details on the event, click here.